tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

HK:1541 Stock Latest News

ImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
Company AnnouncementsImmuneOnco Nears Interim Milestone in Phase III Trial of Lead CD47 Drug IMM01
10d ago
1541
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
PremiumCompany Announcements
ImmuneOnco Wins NMPA Nod to Test Lead CD47 Drug IMM01 in Atherosclerosis
19d ago
1541
ImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
PremiumCompany Announcements
ImmuneOnco Reclaims Global Rights to Key Immuno-Oncology Assets IMM2510 and IMM27M
25d ago
1541
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
PremiumCompany Announcements
ImmuneOnco CEO Increases Stake, Signaling Confidence in Growth
2M ago
1541
ImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
PremiumCompany Announcements
ImmuneOnco’s Phase III Study of Innovative Lymphoma Treatment Approved
2M ago
1541
ImmuneOnco Redeems and Subscribes to Wealth Management Products
PremiumCompany AnnouncementsImmuneOnco Redeems and Subscribes to Wealth Management Products
2M ago
1541
ImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
Premium
Company Announcements
ImmuneOnco Biopharmaceuticals Updates Articles Following Share Placement
2M ago
1541
ImmuneOnco CEO Increases Shareholding, Signaling Confidence in Growth
Premium
Company Announcements
ImmuneOnco CEO Increases Shareholding, Signaling Confidence in Growth
3M ago
1541
ImmuneOnco Advances in Cancer Immunotherapy with New Clinical Trial Milestone
PremiumCompany Announcements
ImmuneOnco Advances in Cancer Immunotherapy with New Clinical Trial Milestone
3M ago
1541
ImmuneOnco Completes HK$345.1 Million H Share Placement
PremiumCompany Announcements
ImmuneOnco Completes HK$345.1 Million H Share Placement
4M ago
1541
ImmuneOnco Announces HK$350.9 Million H Share Placement
PremiumCompany Announcements
ImmuneOnco Announces HK$350.9 Million H Share Placement
4M ago
1541
ImmuneOnco Advances Lung Cancer Treatment with Phase III Trial Application
PremiumCompany Announcements
ImmuneOnco Advances Lung Cancer Treatment with Phase III Trial Application
4M ago
1541
ImmuneOnco Advances Phase III Trial for Innovative Cancer Therapy
PremiumCompany AnnouncementsImmuneOnco Advances Phase III Trial for Innovative Cancer Therapy
4M ago
1541
ImmuneOnco Biopharmaceuticals Reports Promising Interim Results for Oncology Pipeline
Premium
Company Announcements
ImmuneOnco Biopharmaceuticals Reports Promising Interim Results for Oncology Pipeline
5M ago
1541
ImmuneOnco Biopharmaceuticals Begins Phase I Trial for IMC-003/IMM72
Premium
Company Announcements
ImmuneOnco Biopharmaceuticals Begins Phase I Trial for IMC-003/IMM72
6M ago
1541
ImmuneOnco Biopharmaceuticals Schedules Board Meeting for Interim Results
PremiumCompany Announcements
ImmuneOnco Biopharmaceuticals Schedules Board Meeting for Interim Results
6M ago
1541
ImmuneOnco Receives $10 Million Milestone Payment for Cancer Therapy Development
PremiumCompany Announcements
ImmuneOnco Receives $10 Million Milestone Payment for Cancer Therapy Development
6M ago
1541
ImmuneOnco Biopharmaceuticals Reports Unusual Share Price Movements
PremiumCompany Announcements
ImmuneOnco Biopharmaceuticals Reports Unusual Share Price Movements
7M ago
1541
ImmuneOnco’s Partner Receives FDA Clearance for Cancer Therapy Trial
PremiumCompany Announcements
ImmuneOnco’s Partner Receives FDA Clearance for Cancer Therapy Trial
7M ago
1541
ImmuneOnco Biopharmaceuticals Enhances Governance with New Nomination Committee
PremiumCompany AnnouncementsImmuneOnco Biopharmaceuticals Enhances Governance with New Nomination Committee
7M ago
1541
ImmuneOnco Biopharmaceuticals Announces Board Composition and Roles
Premium
Company Announcements
ImmuneOnco Biopharmaceuticals Announces Board Composition and Roles
7M ago
1541
ImmuneOnco Biopharmaceuticals Strengthens Nomination Committee
Premium
Company Announcements
ImmuneOnco Biopharmaceuticals Strengthens Nomination Committee
7M ago
1541

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >